financetom
Business
financetom
/
Business
/
Update: Air Products and Chemicals' Fiscal Q3 Adjusted EPS Rises, Revenue Falls; Provides Q4 Guidance; Shares Up 10%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Air Products and Chemicals' Fiscal Q3 Adjusted EPS Rises, Revenue Falls; Provides Q4 Guidance; Shares Up 10%
Aug 1, 2024 10:34 AM

01:03 PM EDT, 08/01/2024 (MT Newswires) -- (Updates with stock movement in last paragraph.)

Air Products and Chemicals ( APD ) reported Fiscal Q3 adjusted earnings of $3.20 per diluted share on Thursday, up from $2.98 a year earlier.

Analysts polled by Capital IQ expected $3.04 per share.

Revenue for the quarter ended June 30 was $2.99 billion compared with $3.03 billion a year earlier. Analysts surveyed by Capital IQ expected $3.04 billion.

For Q4, the company expects adjusted EPS of $3.33 to $3.63. Analysts surveyed by Capital IQ expect $3.54 per share.

The company reiterated its previous fiscal 2024 adjusted EPS guidance of $12.20 to $12.50. Analysts surveyed by Capital IQ expect $12.25 per share.

Shares of Air Products and Chemicals ( APD ) were up 10% in recent trading.

Price: 290.00, Change: +26.15, Percent Change: +9.91

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bill Ackman eyes IPO of hedge fund Pershing in early 2026, FT reports
Bill Ackman eyes IPO of hedge fund Pershing in early 2026, FT reports
Nov 21, 2025
(Reuters) -Billionaire investor Bill Ackman is aiming to publicly list hedge fund company, Pershing Square Capital Management, early next year, the Financial Times reported on Friday, citing two people briefed on the matter. Talks for the listing are at a preliminary stage and could ultimately be delayed or not lead to a public offering depending on the market conditions, the...
Madrigal Pharmaceuticals Insider Sold Shares Worth $1,082,986, According to a Recent SEC Filing
Madrigal Pharmaceuticals Insider Sold Shares Worth $1,082,986, According to a Recent SEC Filing
Nov 21, 2025
05:43 PM EST, 11/21/2025 (MT Newswires) -- Carole Huntsman, Chief Commercial Officer, on November 21, 2025, sold 1,958 shares in Madrigal Pharmaceuticals ( MDGL ) for $1,082,986. Following the Form 4 filing with the SEC, Huntsman has control over a total of 10,032 common shares of the company, with 10,032 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1157601/000162828025053648/xslF345X05/wk-form4_1763764773.xml ...
US CFPB settles with MoneyLion as enforcement activity winds down
US CFPB settles with MoneyLion as enforcement activity winds down
Nov 21, 2025
* MoneyLion accused of overcharging military personnel on loans * Settlement includes $1.75 million payout * MoneyLion' disagreed with allegations, pleased to settle By Jonathan Stempel NEW YORK, Nov 21 (Reuters) - The U.S. Consumer Financial Protection Bureau reached a $1.75 million settlement with MoneyLion to settle charges that the online lender overcharged military personnel on loans, in possibly one...
United Therapeutics Insider Sold Shares Worth $3,812,082, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $3,812,082, According to a Recent SEC Filing
Nov 21, 2025
05:34 PM EST, 11/21/2025 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on November 20, 2025, sold 8,000 shares in United Therapeutics ( UTHR ) for $3,812,082. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 644,489 common shares of the company, with 130 shares held directly and 644,359 controlled indirectly. SEC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved